Drug Enforcement D-0086-2023

Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL

Status

Terminated

Classification

Class I

Report Date

December 21, 2022

Termination Date

March 15, 2024

Product Information

Product description
Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque (iohexol) 300 mg I/mL, 2.4g Iodine/8 mL in a 10 mL syringe, Compounded with GE Healthcare product, Each mL contains (647 mg) of iohexol as 300 mg of organically bound iodine, 1.21 mg tromethamine, and 0.1 mg edetate calcium disodium, For Injection or oral use; Rx Only, BayCare Central Pharmacy, 7802 Telecom Parkway, Temple Terrace, FL 33637.
Product quantity
250 syringes
Reason for recall
Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL
Recall initiation reason
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
BayCare Health System hospitals in FL

Location & Firm

Recalling firm
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Address
7802 E Telecom Pkwy, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0086-2023
Event ID
91283
Recall initiation date
December 1, 2022
Center classification date
December 22, 2022
Code info
Lot: IOHE2.420221128, Exp. 12/7/2022
More code info